Skip to main content
. Author manuscript; available in PMC: 2022 Sep 22.
Published in final edited form as: Tumour Biol. 2015 Apr 12;36(9):7027–7034. doi: 10.1007/s13277-015-3388-0

Fig. 2.

Fig. 2

Analysis the expression of GSK3β, Wnt5α/β, β-catenin, c-myc, VEGF and cyclin D1 at protein levels in IOMM-Lee and CH157MN cells. Treatments (24 h): control, 25 μM Limonin, 25 μM Tangeritin, 25 μM 6-Gingerol, 25 μM Zerumbone, 25 μM Ganoderic Acid A, and 25 μM Ganoderic Acid DM. a Western blots and b, c Quantitative analysis of GSK3β, Wnt5α/β, β-catenin, c-myc, VEGF, cyclin D1, and GAPDH. *P<.05; **P<.01, significant difference between control and drug treatments